Remepy
Or Shoval is a Co-Founder & CEO at Remepy, with previous experience as a Product Manager at Vamos Ltd. and a Tech Lead at Israeli Military Intelligence. Or also has teaching experience in Modern Philosophy at Ein Prat Academy for Leadership. Or holds a B.A in Liberal Arts and Philosophy & Jewish Thought from Shalem College and attended various educational programs at O.P. Jindal Global University, Máximo Nivel, and IDF Officers Course.
This person is not in any teams
This person is not in any offices
Remepy
Remepy is Pioneering Hybrid Drugs™. We believe that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs™. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™. Remepy’s Digital Molecules™ are designed to be the software components within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug. The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.